“…On the other hand, most studies fully met the test system domain, specifying the parameters used in the management of test substances, for both reporting quality [ 23 , 24 , 25 , 26 , 29 , 30 , 31 , 32 , 33 , 35 ] and methodological quality [ 10 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ], and also the domain related to the doses used and the number of replicates performed, named the administration of test compound, for reporting quality [ 10 , 22 , 23 , 25 , 26 , 28 , 29 , 30 , 33 , 34 ] and methodological quality [ 10 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 32 , 33 , 34 ]. Furthermore, all studies were classified as directly relevant and with an overall low risk.…”